Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,431
Sort by:
India Cervical Cancer Screening Market Outlook 2022
US$ 1,200.00
... India Cervical Cancer Screening Market Outlook 2022” research report discusses all aspects related to the cervical cancer screening market in India. Report gives comprehensive insight on the current accessible cervical screening approaches available in India ...
November 2016
80 pages
Immunodiagnostics Market by Product (Reagents, Instruments, and Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Radioimmunoassay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Rapid Test, and Others) - Global Opportunity Analysis and Industry Forecasts, 2014-2022
US$ 4,432.00
... immunodiagnostics market is segmented on the basis of product, technology, application, end user, and geography. Based on product, the market is divided into reagents ... healthcare infrastructure. Product development and launch is the mostly adopted strategy in the immunodiagnostics market followed by acquisition ...
November 2016
150 pages
2016 Hemostasis Diagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts, Volume Projections for 40 Tests, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers
US$ 34,000.00
... forecasts for 40 hemostasis procedures, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading ... antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation diagnostics practice during the ...
October 2016
750 pages
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers
US$ 51,600.00
... offers specific opportunities and strategies for suppliers. Infectious Diseases Analyzed in the Report AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis ... diagnostic tests, vaccines, drugs and market needs. Review of major analyzers used for infectious disease testing, including their operating characteristics ...
October 2016
2100 pages
2016 Transfusion Diagnostic Analyzers and Reagents in 39 Countries--Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers
US$ 38,000.00
... , grouping and infectious disease screening tests in major countries. Countries Analyzed in the Report Armenia, Australia, Austria, Belgium, Bulgaria, Canada, Croatia ... assays. Review of automated and semi- automated molecular and immunohematology analyzers. Technology Review Assessment of current and emerging technologies, and their ...
October 2016
1025 pages
2016 Europe Molecular Diagnostic Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Technology Trends, Opportunities for Suppliers
US$ 27,600.00
... Emerging technologies Review of molecular diagnostic analyzers Specific product and business opportunities for instrument and consumable suppliers Rationale The molecular diagnostics market is unquestionably the ... of leading molecular diagnostic ;analyzers marketed by Abbott, Beckman Coulter, BD, Bio- Rad, Gen- Probe, Roche, Tecan and other suppliers. Extensive review of molecular diagnostic technologies, test ...
October 2016
1150 pages
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests--Technology Trends, Opportunities for Suppliers
US$ 43,600.00
... microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology ... and Strategic Recommendations Emerging opportunities for new analyzers, reagents kits, IT and other products with ...
October 2016
1000 pages
2016 Molecular Diagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Technology Trends, Opportunities for Suppliers
US$ 38,800.00
... Emerging technologies Review of molecular diagnostic analyzers Specific product and business opportunities for instrument and consumable suppliers Rationale The molecular diagnostics market is unquestionably the ... of leading molecular diagnostic ;analyzers marketed by Abbott, Beckman Coulter, BD, Bio- Rad, Gen- Probe, Roche, Tecan and other suppliers. Extensive review of molecular diagnostic technologies, test ...
October 2016
1600 pages
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opportunities for Suppliers
US$ 46,800.00
... analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers. Rationale Clinical chemistry and immunodiagnostic ... chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature comparison of high- , medium- , and low- volume/POC analyzers. Technology Review ...
October 2016
1650 pages
2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends, Opportunities for Suppliers
US$ 46,880.00
... cancer diagnostic testing. Review of competing/complementing technologies. Companies, universities and research centers developing new cancer diagnostic tests ...
October 2016
1300 pages
2016 Europe Cancer Diagnostic Testing Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends, Opportunities for Suppliers
US$ 34,800.00
... their potential applications for cancer diagnostic testing. Review of competing/complementing technologies. Companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic assessments of major suppliers and start- up firms developing innovative cancer diagnostic technologies and ...
October 2016
925 pages
Global In Vitro Diagnostic Industry Analysis & Forecast Report 2016-2021
US$ 2,600.00
The Global In Vitro Diagnostic Industry Analysis & Forecast Report 2016-2021 is a professional and in-depth study on the current state of the In Vitro Diagnostic industry. The report analysis the global market of In Vitro Diagnostic by main manufactures and geographic regions. The report includes In Vitro Diagnostic definitions, product ...
October 2016
115 pages
U.S. Clinical Oncology Next Generation Sequencing (NGS) Market Size & Forecast By Technology (Whole Genome Sequencing, Whole Exon Sequencing, Targeted Sequencing & Resequencing), By Workflow (NGS Pre-Sequencing, Sequencing, NGS Data Analysis, Primary, Secondary & Tertiary Data Analysis), By End Use (Academic & Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities) And Trend Analysis From 2013 To 2024
US$ 5,950.00
U.S. clinical oncology next generation sequencing market is anticipated to reach USD 1.53 billion by 2024, according to a new report by Grand View Research, Inc. Application of NGS platform for clinical oncology are ...
October 2016
86 pages
Global Capillary Blood Collection Tubes sales Market Report 2016
US$ 3,040.00
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of ...
October 2016
121 pages
Global Oncology Biosimilars Market Research Report 2016
US$ 2,240.00
... the growth of oncology biosimilars market. The Global Oncology Biosimilars Market Research Report 2016 is a valuable source of insightful data for business strategists. It provides the Oncology Biosimilars industry overview with ... GlaxoSmithKline (GSK) Merck Sanofi and Sandoz. Global Oncology Biosimilars Market: Product Segment Analysis Type I Type II Type III Global Oncology Biosimilars Market: Application Segment Analysis Application I Application ...
October 2016
131 pages
Global Oncology Biosimilars Sales Market Report 2016
US$ 3,040.00
The global oncology biosimilars market will witness substantial growth over the forecast period and is ... drivers promoting the growth of oncology biosimilars market. The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical ...
October 2016
125 pages
Global Hormone Refractory Breast Cancer Market Research Report 2016
US$ 2,850.00
2016 Global Hormone Refractory Breast Cancer Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Hormone Refractory Breast Cancer industry, focusing on the ... with: 1.) basic information; 2.) the Asia Hormone Refractory Breast Cancer industry; 3.) the North American Hormone Refractory Breast Cancer industry; 4.) the European Hormone Refractory Breast Cancer industry; 5.) market entry and investment feasibility ...
October 2016
152 pages
Global Oncology Consult Market Research Report 2016
US$ 2,850.00
2016 Global Oncology Consult Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Oncology Consult industry, focusing on the main ... with: 1.) basic information; 2.) the Asia Oncology Consult industry; 3.) the North American Oncology Consult industry; 4.) the European Oncology Consult industry; 5.) market entry and investment feasibility; and ...
October 2016
152 pages
2016 World In Vitro Diagnostic Instrumentation Review
US$ 5,200.00
... low-volume/POC in vitro diagnostic systems within the following market segments: Blood Typing, Grouping, and Screening Cancer Diagnostic Clinical Chemistry and Immunodiagnostics Coagulation Testing Hematology and Flow Cytometry Microbiology Molecular Diagnostics Contains 170 pages
October 2016
170 pages
Global Cancer Generics Market Forecast to 2022
US$ 1,400.00
... expiry of blockbuster cancer drugs is another major factor which is propelling the growth of the cancer generics industry. As per RNCOS report “Global Cancer Generics Market Forecast to 2022”, the global cancer generics market is anticipated ... widely used type of cancer generics drugs. The report also highlights the major cancer generic drugs available in the global market. Furthermore, the global cancer generics market has also been ...
October 2016
110 pages
2016 Global Tumor Marker Diagnostics Market: Competitive Strategies of Leading Suppliers
US$ 2,000.00
... report from VPGMarketResearch.com provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution ...
October 2016
80 pages
2016 Italy Hospital Hemostasis Diagnostics Market
US$ 3,120.00
... 394 pages, 28 tables, and presents a comprehensive analysis of the Italian hospital hemostasis diagnostic testing market, including: Major issues pertaining to the Italian coagulation ... . Volume and sales forecasts for 40 coagulation procedures performed in Italian hospitals, including typical coagulation daily work loads. Review of current instrumentation ...
October 2016
394 pages
2016 Japan Hospital Hemostasis Diagnostics Market
US$ 3,880.00
... 392 pages, 28 tables, and presents a comprehensive analysis of the Japanese hospital hemostasis diagnostic testing market, including: Major issues pertaining to the Japanese coagulation ... . Volume and sales forecasts for 40 coagulation procedures performed in Japanese hospitals, including typical coagulation daily work loads. Review of current instrumentation ...
October 2016
392 pages
2016 Spain Hospital Hemostasis Diagnostics Market
US$ 3,120.00
... 390 pages, 28 tables, and presents a comprehensive analysis of the Spanish hospital hemostasis diagnostic testing market, including: Major issues pertaining to the Spanish coagulation ... . Volume and sales forecasts for 40 coagulation procedures performed in Spanish hospitals, including typical coagulation daily work loads. Review of current instrumentation ...
October 2016
390 pages
2016 In Vitro Diagnostic Technologies and Strategic Profiles of Leading Suppliers
US$ 10,000.00
... of emerging in vitro diagnostic technologies and their potential applications within the following market segments: Blood Typing, Grouping, and Screening Cancer Diagnostics Clinical Chemistry ... of current and emerging suppliers of in vitro diagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products ...
October 2016
170 pages
2016 In Vitro Diagnostics Market: Emerging Technologies and Market Applications
US$ 5,200.00
... of emerging in vitro diagnostic technologies and their potential applications within the following market segments: Blood Typing, Grouping, and Screening Cancer Diagnostics Clinical Chemistry and Immunodiagnostics Coagulation Testing Hematology and Flow Cytometry Microbiology Molecular Diagnostics Technologies analyzed in the ...
October 2016
135 pages